References
- Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853.
- American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl. 1):S11–S61.
- Little RR, La’ulu SL, Hanson SE, et al. Effects of 49 different rare Hb variants on HbA1c measurement in eight methods. J Diabetes Sci Technol. 2015;9(4):849–856.
- Wang Y, Zhang P, Zhou H, et al. Effect of Hb Shuangfeng on HbA1c results. Scand J Clin Lab Invest. 2017;77(5):394–396.
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537–D541.
- Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020.
- Jaisson S, Leroy N, Desroches C, et al. Interference of the most frequent haemoglobin variants on quantification of HbA1c: comparison between the LC-MS (IFCC reference method) and three routinely used methods. Diabetes Metab. 2013;39(4):363–369.
- Rohlfing C, Hanson S, Weykamp C, et al. Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods. Clin Chim Acta. 2016;455:80–83.
- Lou JW, Wang T, Liu YH, et al. Prevalence and molecular characterization of structural hemoglobin variants in the Dongguan region of Guangdong province, Southern China. Hemoglobin. 2014;38(4):282–286.
- Zhang J, Li P, Yang Y, et al. Molecular epidemiology, pathogenicity, and structural analysis of haemoglobin variants in the Yunnan province population of Southwestern China. Sci Rep. 2019;9(1):8264.
- Rohlfing C, Hanson S, Estey MP, et al. Evaluation of interference from hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by fifteen methods. Clin Chim Acta. 2021;522:31–35.
- Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 2014;141(1):5–16.
- Klingenberg O, Furuset T, Hestbråten CR, et al. HbA1c analysis by capillary electrophoresis - comparison with chromatography and an immunological method. Scand J Clin Lab Invest. 2017;77(6):458–464.
- Yun YM, Ji M, Ko DH, et al. Hb variants in Korea: effect on HbA1c using five routine methods. Clin Chem Lab Med. 2017;55(8):1234–1242.
- Little RR, Rohlfing C, Sacks DB. The National Glycohemoglobin Standardization Program: over 20 years of improving hemoglobin A1c measurement. Clin Chem. 2019;65(7):839–848.
- Huang H, Xu L, Chen M, et al. Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China. Sci Rep. 2019;9(1):3493.
- Lin M, Wang Q, Zheng L, et al. Prevalence and molecular characterization of abnormal hemoglobin in Eastern Guangdong of Southern China. Clin Genet. 2012;81(2):165–171.
- Lenters-Westra E, English E. The never ending story of Hb-variants interferences on the measurement of HbA1c. Clin Chim Acta. 2022;532:61–63.
- Xu A, Chen W, Xia Y, et al. Effects of common hemoglobin variants on HbA1c measurements in China: results for α- and β-globin variants measured by six methods. Clin Chem Lab Med. 2018;56(8):1353–1361.
- Klingenberg O. Hemoglobin amino acids by the numbers. Scand J Clin Lab Invest. 2017;77(1):1.